Studies demonstrate that microglia dysfunction contributes to the progression of AD and cognitive decline, and IL-33 can increase microglia phagocytic function while decreasing inflammation in the brain, ultimately improving synaptic plasticity and memory [87]. This evidence concerns the gene IL33 and Alzheimer disease.